cDNA microarray analysis of gene expression in pathologic stage IA nonsmall cell lung carcinomas
- 19 May 2003
- Vol. 97 (11) , 2798-2805
- https://doi.org/10.1002/cncr.11406
Abstract
BACKGROUND The relationship between altered gene expression and tumor progression in lung carcinoma has yet to be characterized. Gene expression in pathologic Stage IA nonsmall cell lung carcinoma specimens was analyzed using a cDNA microarray. METHODS Surgical specimens were used for the current study. The pathologic stage was IA (AJCC) in five tumors, IB in two, IIA in one, IIIA in one, and IIIB in one. Seven tumor specimens were adenocarcinomas and three were squamous cell carcinomas. Paired mRNAs from carcinoma cells and normal lung tissue specimens from the same lobe were labeled with different fluorochromes during cDNA probe synthesis in a reverse‐transcription reaction. Both synthesized, labeled cDNA probes were mixed and hybridized to the microarray. The signal intensity of each spot was measured by laser scanner and gene expression was quantified as the tumor‐to–normal fluorescence ratio (T:N ratio). The gene was overexpressed when the T:N ratio was greater than 2.0 and underexpressed when the ratio was less than 0.5. RESULTS Overall, 40 (9.4%) of the 425 genes evaluated were overexpressed, and 74 genes (17.4%) were underexpressed. In the 5 Stage IA tumor specimens, 31 (7.3%) genes were overexpressed and 76 (17.9%) were underexpressed. For 30 genes (7.1%), expression was different in Stage IA tumor specimens compared with more advanced tumor specimens. CONCLUSIONS The cDNA microarray system showed that numerous alterations of gene expression were present in early‐stage nonsmall cell lung carcinoma specimens. Cancer 2003;97:2798–805. © 2003 American Cancer Society. DOI 10.1002/cncr.11406Keywords
This publication has 27 references indexed in Scilit:
- Bromodeoxyuridine induces keratin protein synthesis at a posttranscriptional level in human lung tumour cell linesDifferentiation, 1999
- Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motilityOncogene, 1999
- Making and reading microarraysNature Genetics, 1999
- Options available — from start to finish — for obtaining expression data by microarrayNature Genetics, 1999
- The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.Journal of Clinical Pathology, 1998
- Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinomaCancer, 1998
- Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancerThe Annals of Thoracic Surgery, 1997
- Use of a cDNA microarray to analyse gene expression patterns in human cancerNature Genetics, 1996
- Over‐expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinomaInternational Journal of Cancer, 1995
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA MicroarrayScience, 1995